Published in Pediatrics on February 01, 1997
Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N Engl J Med (2004) 7.71
Respiratory syncytial virus infection and disease in infants and young children observed from birth in Kilifi District, Kenya. Clin Infect Dis (2008) 3.58
The role of human metapneumovirus in upper respiratory tract infections in children: a 20-year experience. J Infect Dis (2005) 2.02
The absence of enhanced disease with wild type respiratory syncytial virus infection occurring after receipt of live, attenuated, respiratory syncytial virus vaccines. Vaccine (2007) 1.68
Role of respiratory syncytial virus in acute otitis media: implications for vaccine development. Vaccine (2006) 1.10
LDH concentration in nasal-wash fluid as a biochemical predictor of bronchiolitis severity. Pediatrics (2010) 1.10
The pediatric burden of human coronaviruses evaluated for twenty years. Pediatr Infect Dis J (2009) 1.02
Challenges and opportunities in developing respiratory syncytial virus therapeutics. J Infect Dis (2015) 0.96
Effect of zinc salts on respiratory syncytial virus replication. Antimicrob Agents Chemother (2004) 0.94
The incidence and clinical burden of respiratory syncytial virus disease identified through hospital outpatient presentations in Kenyan children. PLoS One (2012) 0.88
Bronchiolitis caused by respiratory syncytial virus in an area of portugal: epidemiology, clinical features, and risk factors. Eur J Clin Microbiol Infect Dis (2003) 0.85
Influenza related hospitalisations in Sydney, New South Wales, Australia. Arch Dis Child (2006) 0.80
Viral Inhibition of the IFN-Induced JAK/STAT Signalling Pathway: Development of Live Attenuated Vaccines by Mutation of Viral-Encoded IFN-Antagonists. Vaccines (Basel) (2016) 0.75
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med (2005) 17.06
The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med (2000) 8.46
The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N Engl J Med (1998) 6.75
No association between fluoridation of water supplies and sudden infant death syndrome. N Z Med J (1991) 4.51
Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol (1998) 4.29
Four modifiable and other major risk factors for cot death: the New Zealand study. J Paediatr Child Health (1992) 4.09
Rates of hospitalization for respiratory syncytial virus infection among children in medicaid. J Pediatr (2000) 4.08
Primary respiratory syncytial virus infection in mice. J Med Virol (1988) 3.77
Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. J Clin Invest (1991) 3.71
Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. J Pediatr (2000) 3.53
Experimental respiratory syncytial virus infection of adults. Possible mechanisms of resistance to infection and illness. J Immunol (1971) 3.33
Bed sharing, smoking, and alcohol in the sudden infant death syndrome. New Zealand Cot Death Study Group. BMJ (1993) 3.14
Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants. Pediatrics (1998) 3.13
Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review. Rev Infect Dis (1992) 3.07
Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics (2001) 2.91
Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine. J Infect Dis (2000) 2.90
Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy. J Infect Dis (2000) 2.90
Periodic fever syndrome in children. J Pediatr (1999) 2.62
Secretory and systemic immunological response in children infected with live attenuated influenza A virus vaccines. Infect Immun (1982) 2.61
A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. J Infect Dis (1994) 2.52
Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics (2001) 2.30
Acellular pertussis vaccines for infants. N Engl J Med (1996) 2.29
Public health policy on bed sharing and smoking in the sudden infant death syndrome. N Z Med J (1995) 2.28
Canine kidney cell line for isolation of respiratory viruses. J Clin Microbiol (1979) 2.25
Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F protein. J Infect Dis (1998) 2.24
Smoking and the sudden infant death syndrome. Pediatrics (1993) 2.22
Natural history of pertussis antibody in the infant and effect on vaccine response. J Infect Dis (1990) 2.18
Epidemiology and clinical impact of parainfluenza virus infections in otherwise healthy infants and young children < 5 years old. J Infect Dis (1997) 2.12
Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection. J Clin Microbiol (1986) 2.09
Influenza-associated morbidity and mortality in young and middle-aged women. JAMA (1999) 2.08
Comparison of competitive and indirect enzyme-linked immunosorbent assays for detection of bluetongue virus antibodies in serum and whole blood. J Clin Microbiol (1987) 2.07
The seroepidemiology of Bordetella pertussis infections: a study of persons ages 1-65 years. J Infect Dis (1996) 2.06
Base deficit stratifies mortality and determines therapy. J Trauma (1992) 1.99
Differing virulence of H1N1 and H3N2 influenza strains. Am J Epidemiol (1980) 1.97
Immunity to influenza A virus infection in young children: a comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine. J Infect Dis (1986) 1.97
Temperature-sensitive mutants of respiratory syncytial virus. J Virol (1969) 1.94
Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience. Pediatr Infect Dis J (2001) 1.90
Comparison of long-term systemic and secretory antibody responses in children given live, attenuated, or inactivated influenza A vaccine. J Med Virol (1985) 1.88
Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children. J Infect Dis (1997) 1.86
Dummies and the sudden infant death syndrome. Arch Dis Child (1993) 1.86
Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccines. J Pediatr (1992) 1.85
The burden of influenza illness in children with asthma and other chronic medical conditions. J Pediatr (2000) 1.85
Pertussis infection in adults with persistent cough. JAMA (1995) 1.84
Streptococcus pneumoniae colonization in the young child: association with otitis media and resistance to penicillin. J Pediatr (1995) 1.84
Ethnic differences in mortality from sudden infant death syndrome in New Zealand. BMJ (1993) 1.80
Sustained transmission of mumps in a highly vaccinated population: assessment of primary vaccine failure and waning vaccine-induced immunity. J Infect Dis (1994) 1.78
Adenovirus infections in young children. Pediatrics (1985) 1.76
Changing presentation of herpes simplex virus infection in neonates. J Infect Dis (1988) 1.76
Influenza virus infections in infants. Pediatr Infect Dis J (1997) 1.75
Long-term visual results and complications in children with aphakia. A function of cataract type. Ophthalmology (1993) 1.74
Risk factors for sudden infant death syndrome following the prevention campaign in New Zealand: a prospective study. Pediatrics (1997) 1.73
Fetal surgery for myelomeningocele and the incidence of shunt-dependent hydrocephalus. JAMA (1999) 1.73
Treatment for acute myelocytic leukemia with allogeneic bone marrow transplantation following preparation with BuCy2. Blood (1991) 1.72
Interlaboratory study evaluating quantitation of antibodies to Haemophilus influenzae type b polysaccharide by enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol (1996) 1.71
Sympathetic activity in patients with panic disorder at rest, under laboratory mental stress, and during panic attacks. Arch Gen Psychiatry (1998) 1.70
Maternal factors in neonatal hypocalcaemia: a study in three ethnic groups. Br Med J (1971) 1.70
Infant room-sharing and prone sleep position in sudden infant death syndrome. New Zealand Cot Death Study Group. Lancet (1996) 1.69
A live attenuated bovine parainfluenza virus type 3 vaccine is safe, infectious, immunogenic, and phenotypically stable in infants and children. J Infect Dis (1995) 1.68
Augmentation of human immunodeficiency virus type 1 neutralizing antibody by priming with gp160 recombinant vaccinia and boosting with rgp160 in vaccinia-naive adults. The NIAID AIDS Vaccine Clinical Trials Network. J Infect Dis (1993) 1.67
Severe ehrlichiosis in an adolescent taking trimethoprim-sulfamethoxazole. Pediatr Infect Dis J (2000) 1.66
Cytomegalovirus pneumonia in two infants recently adopted from China. Clin Infect Dis (1999) 1.65
The natural history of human immunodeficiency virus 1 infection in Haitian infants. Pediatr Infect Dis J (1999) 1.64
Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group. J Infect Dis (1998) 1.64
Immunity to cross-reactive serotypes induced by pneumococcal conjugate vaccines in infants. J Infect Dis (1999) 1.63
A large 4 pi plastic scintillator-detector with clinical applications. Int J Appl Radiat Isot (1967) 1.62
Prevalence and incidence of adult pertussis in an urban population. JAMA (1996) 1.62
Administration of a highly attenuated, live respiratory syncytial virus vaccine to adults and children. Infect Immun (1982) 1.61
Cold-adapted recombinant influenza A virus vaccines in seronegative young children. J Infect Dis (1982) 1.61
Development of subtype-specific and heterosubtypic antibodies to the influenza A virus hemagglutinin after primary infection in children. J Clin Microbiol (1985) 1.59
Modification of a whole room indirect calorimeter for measurement of rapid changes in energy expenditure. J Appl Physiol (1985) (1994) 1.59
Rationale and design of CAPITA: a RCT of 13-valent conjugated pneumococcal vaccine efficacy among older adults. Neth J Med (2008) 1.57
Expression of an antisense hla fragment in Staphylococcus aureus reduces alpha-toxin production in vitro and attenuates lethal activity in a murine model. Infect Immun (1997) 1.56
Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory. Clin Infect Dis (2008) 1.55
Renal noradrenaline spillover correlates with muscle sympathetic activity in humans. J Physiol (1996) 1.54
Serum vitamin A levels in respiratory syncytial virus infection. J Pediatr (1994) 1.53
Hyponatremia in ultradistance triathletes. Med Sci Sports Exerc (1999) 1.53
Description and evaluation of serologic assays used in a multicenter trial of acellular pertussis vaccines. Pediatrics (1995) 1.52
Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta-analysis. Acta Psychiatr Scand (2013) 1.52
Strain-specific serum antibody responses in infants undergoing primary infection with respiratory syncytial virus. J Infect Dis (1988) 1.52
Rat alpha3/beta4 subtype of neuronal nicotinic acetylcholine receptor stably expressed in a transfected cell line: pharmacology of ligand binding and function. Mol Pharmacol (1998) 1.52
Panic disorder: coronary spasm as a basis for cardiac risk? Med J Aust (1998) 1.51
Temperature-sensitive mutants of respiratory syncytial virus: in-vivo studies in hamsters. J Infect Dis (1970) 1.51
Does early hospital discharge with home support of families with preterm infants affect breastfeeding success? A randomized trial. Acta Paediatr (2000) 1.51
The neurocognitive performance of drug-free and medicated euthymic bipolar patients do not differ. Acta Psychiatr Scand (2009) 1.51
Combination vaccines: problems and promise. J Pediatr (2000) 1.51
Comparison of influenza B/Hong Kong virus infections among infants, children, and young adults. J Infect Dis (1980) 1.47
Analysis of intercurrent human immunodeficiency virus type 1 infections in phase I and II trials of candidate AIDS vaccines. AIDS Vaccine Evaluation Group, and the Correlates of HIV Immune Protection Group. J Infect Dis (1998) 1.47
Safety and antigenicity of influenza A/Hong Kong/68-ts-1 (E) (H3N2). J Pediatr (1975) 1.45
Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma. Thorax (2005) 1.44
Searches for Lepton flavor violation in the decays tau{+/-}-->e{+/-}gamma and tau{+/-}-->mu{+/-}gamma. Phys Rev Lett (2010) 1.44